STAT Plus: Sanofi to pay nearly $12 million for illegally using a charity to pay kickbacks to Medicare patients
Sanofi (SNY) has agreed to pay nearly $11.9 million to resolve allegations that donations paid to a charity were actually kickbacks to Medicare patients used to cover out-of-pockets costs for the Lemtrada multiple sclerosis treatment.
This is only the latest instance in which the feds have cracked down on such arrangements between drug makers and patient assistance charities. Over the past two years, some of the biggest names in the pharmaceutical industry — including Pfizer (PFE), a Johnson & Johnson (JNJ) unit, Biogen (BIIB), Amgen (AMGN), and Novartis (NVS) — have reached similar agreements, as have several charities.
Continue to STAT Plus to read the full story…
